Crimson Wine Group (CWGL)
(Delayed Data from OTC)
$6.21 USD
-0.03 (-0.48%)
Updated Sep 18, 2024 10:59 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CWGL 6.21 -0.03(-0.48%)
Will CWGL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CWGL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CWGL
The Zacks Analyst Blog Verizon, Prologis, Medtronic and Crimson
Top Stock Reports for Verizon, Prologis & Medtronic
CWGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Crimson Wine Group (CWGL) Earnings & Sales Fall Y/Y in Q2
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
Zacks Initiates Coverage of Crimson Wine Group With Neutral Recommendation
Other News for CWGL
Top Stock Reports For Verizon, Prologis & Medtronic
Top Analyst Reports For Abbott, BP & Gilead